These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 572736)

  • 21. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
    Quik M; Iversen LL
    Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
    [No Abstract]   [Full Text] [Related]  

  • 22. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA; Nakata C; Nishitani H
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of mazindol on brain dopamine turnover in spiperone-treated rats.
    Fuller RW; Snoddy HD
    J Neural Transm; 1979; 44(1-2):13-9. PubMed ID: 438800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of anterior neostriatal lesions on the behavioural effects of spiroperidol in rats.
    Lowery SP; Barkley P; Baez LA
    Prog Neuropsychopharmacol; 1980; 4(3):269-76. PubMed ID: 7192004
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine metabolism, spiperone binding and adenylate cyclase activity in the adult rat hippocampus after ingrowth of dopaminergic neurones from embryonic implants.
    Bischoff S; Scatton B; Korf J
    Brain Res; 1979 Dec; 179(1):77-84. PubMed ID: 509234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-Tyrosine enhancement of the elevation of 3,4-dihydroxyphenylacetic acid concentration in rat brain by spiperone and amfonelic acid.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Feb; 34(2):117-8. PubMed ID: 6121871
    [No Abstract]   [Full Text] [Related]  

  • 33. Potentiation by spiperone and other butyrophenones of fluid secretion by isolated salivary glands of ixodid ticks.
    Wong DL; Kaufman WR
    Eur J Pharmacol; 1981 Jul; 73(2-3):163-73. PubMed ID: 6273183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG; Sinha YN; Finch CE
    Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased mesolimbic 3H-spiroperidol binding in 4 week old offspring of nursing rat mothers treated with penfluridol.
    Engel J; Lundborg P
    Eur J Pharmacol; 1979 Dec; 60(4):393-5. PubMed ID: 575097
    [No Abstract]   [Full Text] [Related]  

  • 37. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of a partial ergoline with dopamine receptors in vivo and in vitro.
    Fuxe K; Goldstein M; Agnati LF; Köhler C; Lew JY; Okada K
    Acta Physiol Scand; 1983 Feb; 117(2):303-5. PubMed ID: 6869037
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergistic elevation of brain 3,4-dihydroxyphenylacetic acid concentration by methylphenidate and spiperone in control but not reserpine-pretreated rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1979 May; 31(5):339. PubMed ID: 37308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.